Finance

Lists
BAX:NYSE
Baxter International Inc
$28.35
+0.89%
(+0.25) 1D
$28.05
-1.06% (-0.30)
After hours
Closed: Aug 4, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BAX...
Open
$27.74
High
$28.38
Low
$27.48
Mkt. cap
14.66B
Avg. vol.
6.76M
Volume
10.21M
Dividend
0.14%
Quarterly dividend
$0.01
Ex-dividend date
Aug 28, 2026
52-wk high
$30.00
52-wk low
$15.73
EPS
-$2.07
Beta
0.60
Shares outstanding
517.00M
No. of employees
38K
Open
$27.74
High
$28.38
Low
$27.48
Mkt. cap
14.66B
Avg. vol.
6.76M
Volume
10.21M
Dividend
0.14%
Quarterly dividend
$0.01
Ex-dividend date
Aug 28, 2026
52-wk high
$30.00
52-wk low
$15.73
EPS
-$2.07
Beta
0.60
Shares outstanding
517.00M
No. of employees
38K
News stories
From sources across the web
Profile
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
About Baxter International Inc
CEOAndrew Hider
Employees37.5K
Founded1931
HeadquartersDeerfield, Illinois, United States
SectorMedical device
Websitebaxter.com
Analyst ratings
Based on 10 analysts giving stock ratings to BAX in the past 3 months
Hold
Buy
1
Hold
9
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for BAX in the last 3 months.
Highest
Current $28.35
$29.00 (+2.29%)
Average
$25.89 (-8.68%)
Lowest
$21.00 (-25.93%)
Analyst
Recommendation
Action
Price target
Projected
Date
Pito Chickering
Deutsche Bank
Hold
Reiterated
$27.00
-4.8%
07/31/2026
Josh Jennings
TD Cowen
Hold
Maintained
$29.00
+2.3%
07/31/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
$23.00
-18.9%
07/31/2026
Travis Steed
Bank of America Securities
Hold
Reiterated
$28.00
-1.2%
07/30/2026
Joanne Wuensch
Citi
Hold
Upgraded
$28.00
-1.2%
07/31/2026
Rick Wise
Stifel Nicolaus
Hold
Reiterated
$28.00
-1.2%
07/31/2026
Danielle Antalffy
UBS
Hold
Reiterated
$25.00
-11.8%
07/28/2026
David Roman
Goldman Sachs
Hold
Reiterated
$21.00
-25.9%
07/15/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$24.00
-15.3%
07/06/2026
Steven Silver
Argus Research
Hold
Maintained
-
-
05/08/2026
Matt Miksic
Barclays
Buy
Maintained
$27.00
-4.8%
05/04/2026
Patrick Wood
Morgan Stanley
Sell
Maintained
$15.00
-47.1%
02/18/2026
Matthew Taylor
Jefferies
Hold
Reiterated
$19.00
-33%
02/12/2026
Last report
Jul 30, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.56 / $0.37
+52.53%beat
Revenue / Est. (USD)
2.96B / 2.80B
+5.88%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.84B
2.97B
2.70B
2.96B
Cost of goods sold
1.81B
2.01B
1.80B
1.82B
Cost of revenue
1.81B
2.01B
1.80B
1.82B
Research and development expenses
115.00M
116.00M
124.00M
125.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
669.00M
675.00M
658.00M
642.00M
Operating expense
734.00M
741.00M
735.00M
715.00M
Total operating expenses
2.55B
2.76B
2.54B
2.53B
Operating income
287.00M
219.00M
163.00M
427.00M
Other non operating income
2.00M
3.00M
-1.00M
1.00M
EBT including unusual items
121.00M
-756.00M
-6.00M
158.00M
EBT excluding unusual items
228.00M
161.00M
93.00M
364.00M
Income tax expense
172.00M
279.00M
11.00M
23.00M
Effective tax rate
142.15%
-36.90%
-183.33%
14.56%
Other operating expenses
-50.00M
-50.00M
-47.00M
-52.00M
Net income
-46.00M
-1.13B
-15.00M
126.00M
Net profit margin
-1.62%
-37.93%
-0.56%
4.26%
Earnings per share
0.69
0.44
0.36
0.56
Interest and investment income
10.00M
11.00M
12.00M
13.00M
Interest expense
-68.00M
-69.00M
-78.00M
-77.00M
Net interest expenses
-58.00M
-58.00M
-66.00M
-64.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
524.00M
459.00M
400.00M
666.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps